Responses
Oncolytic and local immunotherapy
Original research
TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.